New advances in genetic treatments require continuing medical education for all clinicians caring for individuals with neuromuscular disorders to assure that all eligible patients receive treatments quickly, and to optimize outcomes. Genetic treatments, supplemental treatments, regenerative approaches, and progress toward fetal therapy make this an exciting moment to discuss clinical-decision making. Our goal is to improve use of these powerful new treatments and optimize patient management by including physicians, therapists, nurses, and all providers whether or not they see patients as part of specialized neuromuscular centers.
This in-person 2-day conference (with an option for virtual livestreaming of all formal presentations as well as interactive learning sessions for in-person participants) has the following goals: (1) review and understand new treatment developments over the past year; (2) examine novel insights and clinical reasoning that combine treatments and integrate rehabilitative management; and (3) use specific features of SMA & DMD to model optimal care, helping all providers understand evidence-based medical and rehabilitation approaches, whether or not they are members of specialized Neuromuscular care teams.
The conference will include an educational lecture series providing an overview of the new advances in SMA & DMD disease modifying therapies including gene correction and other course-modifying treatments, approaches to augment function that can be combined with genetic treatments, and developing regenerative and fetal treatments. Complex topics including, disability rights, fatigue and managing orthopedic conditions will be discussed. Didactics will be followed by interactive break-out sessions including clinical cases that exemplify a variety of medical and rehabilitative interventions. These sessions will include opportunities for shared discussion on clinical decision-making for broad and complex phenotypes that clarify the perspectives of multi-disciplinary providers.
At the end of this conference, participants will understand the use of genetic treatments, supplementary functional improvements, and other medical and rehabilitative approaches for SMA & DMD that provide models for optimizing neuromuscular care. Attendees will recognize opportunities to optimize clinical interventions and outcomes.
Registration
There are two ways to attend this hybrid activity: in-person or virtually.
1. In-Person
Registration Fees (Includes course materials, breakfast and lunch, and a certificate of participation)
Early Bird Rates:
Physician - $250
International Physician - $140
AHP/CA Children's Services/Public Health Provider/Administrator/Staff - $200
Industry - $350
Trainee/Resident - $75
Rates after 11/11/2023:
Physician - $300
International Physician - $180
AHP/CA Children's Services/Public Health Provider/Administrator/Staff - $250
Industry - $400
Trainee/Resident - $75
2. Virtually
Registration Fees (Include course material and a certificate of participation. You will receive your Zoom link the week prior to the conference.)
Virtual Early Bird Rates:
Physician - $250
International Physician - $140
AHP/CA Children's Services/Public Health Provider/Administrator/Staff - $200
Industry - $350
Trainee/Resident - $75
Virtual Rates after 11/11/2023:
Physician - $300
International Physician - $180
AHP/CA Children's Services/Public Health Provider/Administrator/Staff - $250
Industry - $400
Trainee/Resident - $75
Tuition may be paid by Visa or MasterCard. Your email address is used for critical information, including registration confirmation, evaluation, and certificate. Be sure to include an email address that you check frequently.
STAP-eligible employees can use STAP funds towards the registration fees for this activity. Complete the STAP Reimbursement Request Form and submit to your department administrator.
Credits
AMA PRA Category 1 Credits™ (14.50 hours), Non-Physician Participation Credit (14.50 hours), ANCC Contact Hours (14.50 hours)
Target Audience
Specialties - Neurology , Neuromuscular Medicine
Professions - Advance Practice Nurse (APN), Fellow/Resident, Non-Physician, Nurse, Occupational Therapist, Physical Therapist, Physician, Registered Nurse (RN), Student
Objectives
At the conclusion of this activity, learners should be able to:
Accreditation
In support of improving patient care, Stanford Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Credit Designation
American Medical Association (AMA)
Stanford Medicine designates this Live Activity for a maximum of 14.50 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
American Nurses Credentialing Center (ANCC)
Stanford Medicine designates this Live Activity for a maximum of 14.50 ANCC contact hours.
Stanford Health Care Department of Rehabilitation is an approved provider for physical therapy, occupational therapy, and speech language pathology for courses that meet the requirements set forth by the respective California Boards. This course is approved for 14.50(s) CEU for PT, OT, and SLP.
Published on 28 September 2023.
